Pre-IPO/PP: The Canandian Bioceutical Corp.

 The Canadian Bioceutical Corp. (CSE: BCC, OTC: CBICF) sucht erneut Kapital über ein Private Placement/Pre-IPO. Man möchte bis zu 20 Mio CAD durch die Ausgabe von ~ 54 Mio Stammaktien (genaue Anzahl abhängig vom Wechselkurs USD/CAD) zu je 0,50 CAD einsammeln. Die erste Tranche des PP steht unmittelbar vor dem Closing, weitere Tranchens sind für April angesetzt. Dei Sperrfrist (Mindesthaltedauer) der Aktien beläuft sich auf 4 Monate +1 Tag. Das frische Kapital möchte man u.a. dazu nutzen, um weitere Aquisitionen und Gründungen von Cannabisunternehmen vorantreiben zu können.

The Canadian Bioceutical Corporation

BCC, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona. While the Company does not directly own, possess or sell cannabis or cannabis-infused products, it does provide substantial support and exerts considerable influence over these two businesses, which are legally authorized to sell medical cannabis and derivative products. Under the Health for Life ("H4L") brand, the two licensed dispensaries operate in the Mesa area, which is part of the rapidly growing Phoenix Metropolitan Statistical Area (MSA) with a population of 4.6 million people. Additionally, the Company supports the Melting Point Extracts ("MPX") brand. The award winning MPX products have facilitated rapid growth of the brand's wholesale business, now supplying a growing number of Arizona dispensaries. The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license. In addition, the Company will continue its efforts related to its legacy nutraceuticals business. Originalmeldung